Press Release Archive

BPGbio, Inc. acquired substantially all of the assets of Berg, LLC, and licenses from Berg, LLC the use of the Berg and Berg Health names.
-
July 25, 2023 |
Media, News and Updates, Press Releases
BPGbio and VELL Health Collaborate to Launch Revolutionary Global Health Initiative to Improve Type 2 Diabetes Outcomes in Guyana
read moreBPGbio, Inc., a leading AI-powered biopharma that focuses on oncology, neurology, and rare diseases, today announced its collaboration with VELL Health, a technology leader in wellness and holistic health, to introduce a groundbreaking holistic health and wellness application for people with Type 2 Diabetes in Guyana. This innovative initiative is part of Guyana’s nationwide pilot program for diabetes clinics which aims to improve healthcare by leveraging mobile technology, data sciences, and holistic health approaches.
-
July 12, 2023 |
Media, News and Updates, Press Releases
BPGbio Announces Partnership with Grupo Terralpe to Offer Groundbreaking AI-Discovered Prostate Cancer Diagnostic Test in Mexico
read moreBPGbio, Inc., a leading AI-powered biopharma that focuses on oncology, neurology and rare diseases, today announced that it has signed a collaborative agreement with Grupo Terralpe, Inc., a renowned private investment group based in Mexico City and Boston, Mass. Together, the companies will commercialize the pstateDx™ test, BPGbio’s prostate cancer diagnostic test, in Mexico.
-
July 10, 2023 |
Media, News and Updates, Press Releases
Former CDC Director and Renowned Physician-Scientist Dr. Robert Redfield Joins BPGbio Scientific Advisory Board
read more -
June 6, 2023 |
Media, News and Updates, Press Releases
BPGbio Announces First Patients Dosed in Phase 2 Trial of AI-Developed BPM 31510 for Glioblastoma Multiforme
read moreBPGbio, Inc., a leading AI-powered biopharma that focuses on oncology, neurology and rare diseases, today announced that patients have been initially dosed in its Phase 2 trial for BPM 31510 for Glioblastoma Multiforme (GBM), a fast-growing and aggressive form of brain cancer.
-
May 22, 2023 |
Press Releases, Media, News and Updates
BPGbio Announces New Partnership with DoD Focused on AI-Guided Breast Cancer Diagnostics
read moreBPGbio, Inc., a leading AI-powered biopharma that focuses on oncology, neurology and rare diseases, today announced that it will continue clinical validation of a novel breast cancer diagnostic panel that was developed under a previous agreement with the Department of Defense’s Clinical Breast Care Project (CBCP), including the DoD’s Uniformed Services University of the Health Sciences (USU), The Windber Research Institute, and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF). The new panel, developed with AI, is designed to identify women who are diagnosed with ER+ breast cancer but do not respond to hormone therapy, so that more effective options could be offered to improve treatment response.
-
April 13, 2023 |
Press Releases, News and Updates
BPGbio Announces Oncology Drug Pipeline and Prostate Cancer Biomarker Developments at AACR
read moreBPGbio, Inc., a leading AI-powered biopharma that focuses on oncology, neurology and rare diseases, today announced that novel data insights from its oncology therapeutics and diagnostics portfolio will be presented at the American Association for Cancer Research (AACR) Annual Meeting in Orlando, April 14 – 19, 2023.